Competition in today’s global pharmaceutical and related industries has reached unprecedented levels and TELSTAR has launched the Lyozeta Series of freeze-dryers for those companies searching for ways to increase competitive edge. Lyozeta Series are state of the art freeze-drying systems, designed and engineered modularly to provide a comprehensive range of standard models and in-factory options. Lyozeta Series constitute a well-proven standard solution and provide the right balance between specification, quality, cost and lead-time. To ensure the equipment meet the specific requirements of a client as well as the current industry guidelines (cGMP, ASME BPE, 21 CFR Part 11, cGAMP, etc), a Project Manager manages each project against a Qualification Project Plan (QPP) and assists in the Factory Acceptance Test (FAT) and Site Acceptance Test (SAT). The aim is to more easily provide the client with fast trouble-free commissioning and on site validation. Engineering and manufacturing practices in all TELSTAR facilities follow ISO 9001:2000 quality standards and are certified according to industry guidelines. Lyozeta models can be easily integrated with other systems manufactured by TELSTAR: LAFs, o-RABS, c-RABS, isolators, semi-automatic and automatic loading/ unloading systems for vials and bulk applications. TELSTAR is now one of the few players that can guarantee a fully integrated package.
The LyoZeta freeze dryer series are designed to perform clinical trials, pilot and large scale industrial freeze drying processes, in accordance with the strictest GMP and regulatory standards and in line with the latest freeze drying technology trends. Telstar LyoZeta Series are state of the art freeze-drying systems, designed and engineered modularly to provide a comprehensive range of standard models and in-factory options. The LyoZeta Series constitutes a well-proven standard solution and provides the right balance between specification, quality, cost and lead-time.